Literature DB >> 17318319

Peripheral iris depigmentation and ocular hypotony: result of the natural course of non-treated Vogt-Koyanagi-Harada (VKH) disease.

Sonia Attia1, Sonia Zaouali, Abdelbasset Bettaieb, Salim Ben Yahia, Moncef Khairallah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17318319     DOI： 10.1007/s10792-007-9048-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN： 0165-5701            Impact factor:   2.029


× No keyword cloud information.
  5 in total

1.  Symmetric peripheral iris depigmentation in vogt-koyanagi-harada syndrome.

Authors:  Eric B Suhler; Ronald R Buggage; Robert B Nussenblatt; Ron Neumann
Journal:  Arch Ophthalmol       Date:  2002-08

2.  Iris atrophy, serous detachment of the ciliary body, and ocular hypotony in chronic phase of Vogt-Koyanagi-Harada disease.

Authors:  J M Saari; K Nummelin
Journal:  Eur J Ophthalmol       Date:  2005 Mar-Apr       Impact factor: 2.597

3.  Swollen ciliary processes as an initial symptom in Vogt-Koyanagi-Harada syndrome.

Authors:  R Kimura; M Kasai; K Shoji; C Kanno
Journal:  Am J Ophthalmol       Date:  1983-03       Impact factor: 5.258

4.  Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease.

Authors:  K Yamaki; K Gocho; K Hayakawa; I Kondo; S Sakuragi
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

Review 5.  Vogt-Koyanagi-Harada syndrome.

Authors:  R S Moorthy; H Inomata; N A Rao
Journal:  Surv Ophthalmol       Date:  1995 Jan-Feb       Impact factor: 6.048
  5 in total
  2 in total

1.  Posterior segment recurrences in Vogt-Koyanagi-Harada disease.

Authors:  Nishant Sachdev; Vishali Gupta; Amod Gupta; Ramandeep Singh
Journal:  Int Ophthalmol       Date:  2007-09-26       Impact factor: 2.031

Review 2.  Vogt-Koyanagi-Harada syndrome - current perspectives.

Authors:  Abeir Baltmr; Sue Lightman; Oren Tomkins-Netzer
Journal:  Clin Ophthalmol       Date:  2016-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.